What happens after you learn you have a hereditary cancer risk?
For many people, the answer is uncertainty. Genetic testing can provide important information, but it often leaves individuals wondering what to do next, which specialists to see, and how to navigate the emotional weight of the decisions ahead.
In this episode, I sit down with Randi Eichenbaum, founder of MOTA, to talk about her personal journey, the gaps she saw in hereditary cancer support, and how those experiences led her to create a platform designed to help people navigate complex medical decisions with greater clarity and confidence.
We discuss the unique challenges facing BRCA carriers and previvors, where traditional healthcare systems often fall short, and why having a personalized roadmap can make all the difference. Randi also shares how MOTA helps individuals understand their options, connect with trusted specialists, and feel supported throughout every stage of their journey.
Whether you're navigating genetic testing, living with a BRCA mutation, supporting a loved one, or simply interested in improving patient advocacy and healthcare navigation, this conversation offers valuable insight and hope.
MOTA is a navigation and community platform for people with increased hereditary cancer risk, starting with women who carry a BRCA mutation. MOTA offers a personalized, guideline-based roadmap, vetted specialists, and a community that gets it. Built by a BRCA2+ survivor who created what she wished she'd had. Free at MOTA.care.
Learn more: MOTA.care
Follow MOTA on Instagram: @mota.care
If you enjoyed this episode, please subscribe, leave a review, and share it with someone who may benefit from this conversation.
","author_name":"Marisa Stachelski"}